Analysis Topic: Companies Analysis
The analysis published under this topic are as follows.
Tuesday, November 02, 2021
Could This $3 Stock Disrupt the $12 Trillion Healthcare Industry? / Companies / Healthcare Sector
By: Submissions
The US health and medical insurance industry is a $1.1-trillion maze that is impossible to navigate.And in the bigger scenario of a massive $11-trillion-plus global healthcare industry, America is definitely not first.
Americans are fed up, and a digital revolution that goes way beyond telemedicine is the only thing that will restore control.
Fixing it is a highly disruptive, multi-trillion-dollar opportunity.
Telemedicine, or ‘Telehealth’, will soar from $42 billion in 2018 to $400 billion in 2026.
Healthcare IT alone will be worth $390 billion by 2024.
Thursday, October 21, 2021
Why A.I. Is About To Trigger The Next Great Medical Breakthrough / Companies / Healthcare Sector
By: OilPrice_Com
The healthcare industry is one of the fastest growing in the world, but today, it's seeing a major disruption.
With everything from work meetings to family gatherings going digital since 2020, this mammoth $12 trillion industry is joining the new tech renaissance to deliver a much-needed overhaul.
That’s why trillion dollar Big Tech companies like Google, Amazon, and Apple are all trying to make a move into healthcare.
Now, the way people make decisions about their health is beginning to look drastically different from how it did 24 months ago.
The Wall Street Journal says, "Tech advances put the annual doctor visit on the critical list."
And Forbes says, "Artificial intelligence offers an unprecedented opportunity to... reshape the practice of healthcare."
Wednesday, August 18, 2021
Tapping Into A Massive $53 Billion Healthcare Market / Companies / Healthcare Sector
By: Submissions
...
Tuesday, January 19, 2021
This Small Company Could Revolutionize The Trillion-Dollar Drug Sector / Companies / Healthcare Sector
By: OilPrice_Com
...
Tuesday, December 22, 2020
How Your Smartphone Can Fix America’s Healthcare Crisis / Companies / Healthcare Sector
By: Stephen_McBride
At 30,000 feet in the air, a passenger was suddenly crippled by severe chest pains. The flight attendant called over the loudspeaker, “Is there a doctor on board?” A tall man rose from seat 6C. And the first thing Dr. Eric Topol reached for was his iPhone.
He plugged a credit card-sized heart monitor into the phone and placed it on the woman’s chest. The doctor didn’t need fancy machines to diagnose the problem. An iPhone app showed she was on the verge of a major heart attack.
Topol recommended the pilot make an emergency landing. The passenger was rushed to the hospital and survived.
Read full article... Read full article...
Saturday, December 19, 2020
Liu Qiangdong Reaps the Harvest of JD Health's White-Hot IPO / Companies / Healthcare Sector
By: Sumeet_Manhas
...
Friday, June 19, 2020
“AI Healthcare” Stocks Will Mint the World’s First Trillionaire / Companies / Healthcare Sector
By: John_Mauldin
You won’t read about these stocks in the mainstream media. The average investor doesn’t even know they exist. But don’t let that fool you: because a small “hidden” group of companies is figuring out how to merge artificial intelligence with medical technology.
I call them “AI healthcare stocks.” In a minute, I’ll tell you why they’re hands down the #1 way to make big money in AI stocks. But first you must understand: not everyone’s excited about AI.
Some folks are even scared of it. They think AI could eventually try to wipe out the human race. They imagine human-like robots like Ava from the film Ex Machina or Skynet—the computer program that tried to wipe out the human race in the Terminator movies.
Read full article... Read full article...
Saturday, January 25, 2020
JOHNSON & JOHNSON (JNJ) Big Pharama AI Mega-trend Investing 2020 / Companies / Healthcare Sector
By: Nadeem_Walayat
The juggernaut that is Artificial Intelligence continues to rumble along towards an inexorable future, one that most still fail to grasp the magnitude of the changes that are just around the corner as humans think in linear terms whilst the AI trend is EXPONENTIAL. Where developments that even the proponents of AI thought would take several years are taking place in mere MONTHS! That is the power of the unfolding AI MEGA-TREND!
AI has already CHANGED THE WORLD! EXPONENTIALLY! You have an AI super computer right in your pocket for likely less than £1000!
Especially, when one marries AI with other big world changing tech mega-trend "Quantum Computing"! Put the 2 together and we are literally going to see an explosion in SUPER INTELLGENCE that would soon far exceed that of human intelligence, following which it won't be that many years before the AI exceeds the intelligence of the sum of ALL humans! For better or worse, that's the path we are on.
Read full article... Read full article...
Tuesday, December 31, 2019
3 Ways to Play the Ageing Population Healthcare Surge / Companies / Healthcare Sector
By: Robert_Ross
2019 was a good year for stocks.US stocks have rocketed 28% this year. This is the second largest annual gain since 1999. And the tenth straight year stocks have climbed higher.
This has a lot of investors worried that stocks could tank soon. But this bull market is far from over. My research shows stocks should continue to rise until at least September 2020.
And falling interest rates could help that happen… especially for healthcare stocks.
Read full article... Read full article...
Wednesday, October 02, 2019
Walmart Is Quietly Turning Healthcare on Its Head / Companies / Healthcare Sector
By: Stephen_McBride
Was Obamacare good for the average American family? Before you answer, look at this chart...
It shows the stock performance of UnitedHealth (UNH), America’s biggest health insurance company, since 2010:
Saturday, August 17, 2019
JOHNSON AND JOHNSON - JNJ for Life Extension Pharma Stocks Investing / Companies / Healthcare Sector
By: Nadeem_Walayat
We are currently galloping full speed along an exponential curve that unlike the neural nets of the 1990's, that promised a lot but delivered very little, this time it really looks like we are on the verge of AI success, not only that but it heralds changes in every aspect of our lives most of which we cannot even imagine today, hence the term the singularity is often used, the AI event horizon beyond which we cannot see.
My latest analysis in this series focuses on how to profit and capitalise on the unfolding machine intelligence driven mega-trend through investing in leveraged to AI Human Life Extension stocks.
Read full article... Read full article...
Thursday, July 11, 2019
Investing in Life Extending Pharma Stocks / Companies / Healthcare Sector
By: Nadeem_Walayat
We are currently galloping full speed along an exponential curve that unlike the neural nets of the 1990's, that promised a lot but delivered very little, this time it really looks like we are on the verge of AI success, not only that but it heralds changes in every aspect of our lives most of which we cannot even imagine today, hence the term the singularity is often used, the AI event horizon beyond which we cannot see.
My latest analysis in this series focuses on how to profit and capitalise on the unfolding machine intelligence driven mega-trend through investing in leveraged to AI Human Life Extension stocks.
Read full article... Read full article...
Wednesday, July 03, 2019
Investing to Profit and Benefit from Human Life Extension AI Stocks and Technologies / Companies / Healthcare Sector
By: Nadeem_Walayat
We are currently galloping full speed along an exponential curve that unlike the neural nets of the 1990's, that promised a lot but delivered very little, this time it really looks like we are on the verge of AI success, not only that but it heralds changes in every aspect of our lives most of which we cannot even imagine today, hence the term the singularity is often used, the AI event horizon beyond which we cannot see.
This my latest analysis on how to capitalise on the unfolding machine intelligence mega-trend through investing in leveraged to AI stocks, though artificial intelligence should more accurately be termed as Super Intelligence for AI will only be comparable to human intelligence for a brief period of time, perhaps no more than a few short months before AI starts leaving us behind, as we will largely remain stuck in that which our 1300cc or so of grey matter can process, where even the likes of today's Einstein's in comparison will have mice like cognition within a decade or so of the machine intelligence first surpassing humans that will likely prompt many to seek to merge with the machine intelligence to go beyond biological constraints to enhance cognitive abilities such as in memory storage and access.
Read full article... Read full article...
Wednesday, August 30, 2017
Why Trump Should Literally Start Selling American Blood To China / Companies / Healthcare Sector
By: John_Mauldin
BY PATRICK WATSON : In June, the US ran a $32.6 billion “trade in goods” deficit with China. That’s the difference between our imports from China ($42.3 billion) and our exports to China ($9.7 billion), according to the US Census Bureau.
That sounds terrible, but it’s really not if you look at the big picture.
The Trump administration doesn’t like trade deficits, so they must be reduced or eliminated. To do that, we need Chinese consumers to buy more “Made in the USA” products.
Read full article... Read full article...
Tuesday, January 24, 2017
The Future of Pharma In The Age Of Trump / Companies / Healthcare Sector
By: John_Mauldin
BY PATRICK COX : Last week, Donald Trump complained about drug prices in a press conference. Drug companies, he said, are “getting away with murder.” During that presser, pharma and biotech stocks lost over $20 billion in value.
Investors should have learned an important lesson. They probably didn’t.
Trump’s targeting of drug sellers was not a fluke. Hillary Clinton's "price gouging" tweet last September had the same type of impact on markets.
Read full article... Read full article...
Saturday, January 21, 2017
Cryobanking Could Solve The Transplant Organ Shortage / Companies / Healthcare Sector
By: John_Mauldin
BY PATRICK COX : What’s the one medical condition most likely to kill you? If you follow statistics, you'd probably say heart disease. Each year, more than a million Americans have a heart attack. And about one in four deaths in the US is due to the condition.
Though heart disease tops most "causes of death" lists, far more Americans die due to the transplant organ shortage. And heart transplants could prevent most cardiac arrest deaths.
Read full article... Read full article...
Tuesday, January 17, 2017
The One Stock to Retire On / Companies / Healthcare Sector
By: OilPrice_Com
Dear Reader,
A little-known biotech company is about to answer the biggest medical question of our time:
Am I going to have a stroke?
And you’ll get an answer in about 40 seconds.
Read full article... Read full article...
Tuesday, December 20, 2016
Trump’s FDA Chief May Implement Progressive Approval for Drugs / Companies / Healthcare Sector
By: John_Mauldin
BY PATRICK COX : President-elect Trump's cabinet appointments are generating a great deal of attention and controversy. After eight years of Democrat rule, it would be foolish to expect otherwise.
One appointment, though, will have a profound impact on your health… and the health of your loved ones.
Read full article... Read full article...
Wednesday, November 09, 2016
The Cannabis Sector after the Vote – Boom or Bust?? / Companies / Healthcare Sector
By: TLSReport
Technical Analyst Clive Maund takes a look at the cannabis sector, and how the the election results for eight states, including California, might facilitate a massive boom.
Not only do we have the US elections today, we also have voting in eight states on the legalization of cannabis, including the all-important State of California, which just by itself is one of the biggest economies in the world. The outcome of this vote is of crucial importance to the future of this fledgling industry, although all the indications are that it will be favorable.
Read full article... Read full article...
Sunday, July 24, 2016
Sernova, Diabetes and Haemophilia / Companies / Healthcare Sector
By: Richard_Mills
Paul Lacey was a researcher at Washington University when, in 1972, he cured some diabetic rats by transplanting the islet cells from healthy rats into diabetic ones.
Over the next two decades researchers made many attempts to apply the procedure to humans. Unfortunately no one was successful. By the early 1990’s most scientists had come to the conclusion that islet-cell transplantation was a lost cause.
Drs. James Shapiro, Jonathan Lakey and colleagues from the University of Alberta in Edmonton were successful at improving the treatment of a select group with severe diabetes through development of the Edmonton protocol in the late 1990s.
Read full article... Read full article...